The qualification of service providers performing outsourced activities within a GDP environment is essential to ensure the quality and integrity of medicinal products. In line with the EU GDP Guidelines, a documented, risk-based approach, including formal assessment, audits where appropriate, quality agreements, and ongoing performance monitoring, is required to ensure continued compliance with regulatory requirements.
